SCHEMBL6385398

SCHEMBL6385398

NC(=O)C[C@@]1(n2ccc(N)nc2=O)O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.47
MTOR P42345 2/20 0.47
THRB P10828 1/20 0.47
MDM2 Q00987 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
PDE3A Q14432 3/20 0.45
PDE4D Q08499 1/20 0.45
SLC29A1 Q99808 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
CACNA1F O60840 2/20 0.36
ALB P02768 2/20 0.36
MAPT P10636 2/20 0.36
CACNA1D Q01668 2/20 0.36
CACNA1S Q13698 2/20 0.36
CACNA1C Q13936 2/20 0.36
POLA1 P09884 1/20 0.34
GMNN O75496 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30562888 0.89 LMNA (0.44) LMNAMTORTHRBMDM2NCOA1
SCHEMBL3272285 0.88 LMNA (0.51) LMNAMTORTHRBMDM2NCOA1
SCHEMBL1896532 0.86 LMNA (0.49) LMNAMTORTHRBMDM2NCOA1
SCHEMBL2180644 0.86 LMNA (0.49) LMNAMTORTHRBMDM2NCOA1
SCHEMBL31070840 0.86 LMNA (0.49) LMNAMTORTHRBMDM2NCOA1
SCHEMBL7775032 0.85 LMNA (0.48) LMNAMTORTHRBMDM2NCOA1
SCHEMBL18936267 0.85 LMNA (0.41) LMNAMTORTHRBMDM2NCOA1
Phosphoric Acid SCHEMBL16655013 0.84 LMNA (0.47) LMNAMTORTHRBMDM2NCOA1
Phosphoric Acid SCHEMBL21645281 0.84 LMNA (0.47) LMNAMTORTHRBMDM2NCOA1
SCHEMBL15239320 0.84 LMNA (0.47) LMNAMTORTHRBMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501850-A2 NUCLEOSIDE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION GENELABS TECHNOLOGIES, INC. (US) 2005-02-02 EP claimed
WO-2003093290-A2 NUCLEOSIDE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION GENELABS TECHNOLOGIES, INC. (US) 2003-11-13 WO claimed
CN-115919776-A Mixed lipid material nano preparation of pig spleen extract and application thereof 浙江丰安生物制药有限公司 2023-04-07 CN disclosed
CN-112826808-B Neutral/cation mixed lipid nano preparation of cyclic dinucleotide or analogue thereof and application thereof 北京大学 2022-03-25 CN disclosed